Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
MaryKate Lesnevich, Bristol Myers Squibb, USA; Kelly Soady, Oxford Pharmagenesis, UK; Eileen Burkart-Hartman, Takeda Pharmaceuticals USA, Inc., USA; Doreen Valentine, International Society for Medical Publications Professionals, USA; Vidhi Vashisht, Krystelis Ltd.,...
Your team at a sponsoring pharmaceutical company recently published a clinical study in a reputable journal. Soon after, a healthcare professional shared a summary generated by an AI-powered medical tool that appears to overstate the study’s efficacy and...
Perspectives from the ISMPP Academy 2025 session titled “Connecting the Dots: Alignment and Synergies in Medical Communications” Introduction Publications, medical education, and scientific content teams often sit at the center of a dense stakeholder network that...
As artificial intelligence (AI) continues to advance, its integration into the field of medical research and publication is increasing. The ISMPP Publication Ethics & Standards Committee, in collaboration with the ISMPP AI Task Force, is interested in...
